What’s the import and export situation of medical dressing in China?

And what are the prospects of this industry?

Today, pharmaceutical and medical devices online platform, Ddu, brings you the breakdown with our Medical Dressing Market Analysis Report.

As one of the most critical medical products, medical dressing plays a significant role in the import and export trade of China.

Common cotton (including absorbent cotton, gauze and bandage etc.) currently holds the dominant position in the Chinese medical dressing market. These products, made of natural materials, make up over 50% of the market.

Product homogenization, low value-added and insufficient technologies are the basic industry problems. Export companies mainly rely on OEM exports in short of their own brands and sales channels in the international market.

In 2013, the number of countries China exported medical dressing to, totaled at 195, among which North America, Europe and Asia were the main export markets and their export sales were an estimated 8.03 trillion USD, 7.82 trillion USD and 4.62 trillion USD respectively.

In regards to the countries and regions, the top ten export markets were the United States, Germany, Japan, Britain, France, the Netherlands, Italy, Belgium, Venezuela and Australia whose combined export volume totaled 1.639 billion USD, accounting for 68.86% of all exports.

Due to the current saturated trends and fierce competition in European and American markets, medical dressing export companies are now focusing on the developing nations. The year 2013 witnessed a dramatic increase in the markets of emerging nations like Latin America.

Regarding these companies, 51 had exports that totaled at over 10 million USD. Among this 51, 19 companies had exports that totaled an estimated 20 million USD.

The Prospects of medical dressings

According to experts at Ddu, a cross-border medical trade platform, with the increasing demand for multi-functional, new materials and high value-added medical dressing, they predict that the domestic medical dressing production structure will gradually develop towards high-end products.

Innovation of medical dressing products is mainly reflected in the innovation of the product material manufacturing process. However, medical dressing products with technology content accounts  for less than 10% of the Chinese export market. Also consider the fact that development of new products and investment in research  is far lower in China than in developed counties.

Thus, adjusting business strategies, cultivating original brands and increased investment in research and development of high-end new medical dressings products will be some of the common challenges for medical dressing export companies in China.

Revitalization, development, standardization and progress of the Chinese medical dressing industry will be our shared expectation and mission.